Low-dose ofatumumab for multidrug-resistant nephrotic syndrome in children: a randomized placebo-controlled trial
Pietro Ravani, Isabella Pisani, Monica Bodria, Gianluca Caridi, Maria Ludovica Degl’Innocenti, Gian Marco Ghiggeri
Topics & Concepts
MedicinePlaceboInternal medicineKidney diseaseNephrologyNephrotic syndromeRandomized controlled trialUrologyRituximabRenal functionGastroenterologySurgeryPathologyAlternative medicineLymphomaRenal Diseases and GlomerulopathiesRenal Transplantation Outcomes and TreatmentsChronic Kidney Disease and Diabetes